"Northwestern Medicine is proud to have five hospitals ranked among “America’s Best” by U.S. News & World Report, 2021-22. Anchored by Northwestern Memorial Hospital, the #1 hospital in Illinois and a top 10 hospital in the nation, we’re leading the quest for better care and better treatments in the Chicagoland area. With more than 200 locations across Chicagoland, better care and better treatments are never far from home. To learn more, visit our website."

During the past decade, Northwestern Medicine Digestive Health Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern Medicine Digestive Health Center" #1 collaborator was "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern Medicine Digestive Health Center" are "Bacterial Overgrowth Syndrome" (1 trials), "Eosinophilic Gastritis" (1 trials), "Eosinophilic Gastroenteritis" (1 trials), "Irritable Bowel Syndrome" (1 trials) and "Nonalcoholic Fatty Liver" (1 trials). Many other conditions were trialed in "Northwestern Medicine Digestive Health Center" in a lesser frequency.

Most popular intervention types in "Northwestern Medicine Digestive Health Center" are "Behavioral" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atrantil (Medical Food)" (1 trials), "Dupilumab (blinded)" (1 trials), "Dupilumab (open-label)" (1 trials), "Low FODMAP Diet" (1 trials) and "Placebo (blinded)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Medicine Digestive Health Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Northwestern Medicine Digestive Health Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Northwestern Medicine Digestive Health Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Medicine Digestive Health Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".